These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12609661)

  • 1. Development of a LC method for pharmaceutical quality control of the antimetastatic ruthenium complex NAMI-A.
    Bouma M; Nuijen B; Jansen MT; Sava G; Picotti F; Flaibani A; Bult A; Beijnen JH
    J Pharm Biomed Anal; 2003 Feb; 31(2):215-28. PubMed ID: 12609661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photostability profiles of the experimental antimetastatic ruthenium complex NAMI-A.
    Bouma M; Nuijen B; Jansen MT; Sava G; Bult A; Beijnen JH
    J Pharm Biomed Anal; 2002 Nov; 30(4):1287-96. PubMed ID: 12408919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A.
    Bouma M; Nuijen B; Jansen MT; Sava G; Flaibani A; Bult A; Beijnen JH
    Int J Pharm; 2002 Nov; 248(1-2):239-46. PubMed ID: 12429477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical development of a parenteral lyophilized formulation of the antimetastatic ruthenium complex NAMI-A.
    Bouma M; Nuijen B; Sava G; Perbellini A; Flaibani A; van Steenbergen MJ; Talsma H; Kettenes-van den Bosch JJ; Bult A; Beijnen JH
    Int J Pharm; 2002 Nov; 248(1-2):247-59. PubMed ID: 12429478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy of the antimetastatic compound NAMI-A and electroporation on B16F1 tumour cells in vitro.
    Bicek A; Turel I; Kanduser M; Miklavcic D
    Bioelectrochemistry; 2007 Nov; 71(2):113-7. PubMed ID: 17602896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.
    Ravera M; Baracco S; Cassino C; Zanello P; Osella D
    Dalton Trans; 2004 Aug; (15):2347-51. PubMed ID: 15278129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation.
    Bacac M; Hotze AC; van der Schilden K; Haasnoot JG; Pacor S; Alessio E; Sava G; Reedijk J
    J Inorg Biochem; 2004 Feb; 98(2):402-12. PubMed ID: 14729322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruthenium antimetastatic agents.
    Alessio E; Mestroni G; Bergamo A; Sava G
    Curr Top Med Chem; 2004; 4(15):1525-35. PubMed ID: 15579094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.
    Rademaker-Lakhai JM; van den Bongard D; Pluim D; Beijnen JH; Schellens JH
    Clin Cancer Res; 2004 Jun; 10(11):3717-27. PubMed ID: 15173078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and mechanistic investigation into the possible activation of imidazolium trans-[tetrachloridodimethylsulfoxideimidazoleruthenate(III)], NAMI-A, by 2-mercaptoethane sulfonate.
    Adigun RA; Martincigh B; Nyamori VO; Omondi B; Masimirembwa C; Simoyi RH
    Dalton Trans; 2014 Sep; 43(34):12943-51. PubMed ID: 25026023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.
    Sava G; Bergamo A; Zorzet S; Gava B; Casarsa C; Cocchietto M; Furlani A; Scarcia V; Serli B; Iengo E; Alessio E; Mestroni G
    Eur J Cancer; 2002 Feb; 38(3):427-35. PubMed ID: 11818210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration.
    Cocchietto M; Zorzet S; Sorc A; Sava G
    Invest New Drugs; 2003 Feb; 21(1):55-62. PubMed ID: 12795530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form.
    Mazuryk O; Kurpiewska K; Lewiński K; Stochel G; Brindell M
    J Inorg Biochem; 2012 Nov; 116():11-8. PubMed ID: 23010324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actin-dependent tumour cell adhesion after short-term exposure to the antimetastasis ruthenium complex NAMI-A.
    Sava G; Frausin F; Cocchietto M; Vita F; Podda E; Spessotto P; Furlani A; Scarcia V; Zabucchi G
    Eur J Cancer; 2004 Jun; 40(9):1383-96. PubMed ID: 15177498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion.
    Gava B; Zorzet S; Spessotto P; Cocchietto M; Sava G
    J Pharmacol Exp Ther; 2006 Apr; 317(1):284-91. PubMed ID: 16368900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
    Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
    J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine.
    Sava G; Gagliardi R; Bergamo A; Alessio E; Mestroni G
    Anticancer Res; 1999; 19(2A):969-72. PubMed ID: 10368640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium anticancer drugs and proteins: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c.
    Casini A; Mastrobuoni G; Terenghi M; Gabbiani C; Monzani E; Moneti G; Casella L; Messori L
    J Biol Inorg Chem; 2007 Nov; 12(8):1107-17. PubMed ID: 17680283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells.
    Frausin F; Cocchietto M; Bergamo A; Scarcia V; Furlani A; Sava G
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):405-11. PubMed ID: 12439599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spectroscopic study of the reaction of NAMI, a novel ruthenium(III)anti-neoplastic complex, with bovine serum albumin.
    Messori L; Orioli P; Vullo D; Alessio E; Iengo E
    Eur J Biochem; 2000 Feb; 267(4):1206-13. PubMed ID: 10672032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.